Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Conatus Pharmaceuticals Inc Announces Completion Of IPO-Form 8-K

Thursday, 1 Aug 2013 04:56pm EDT 

Conatus Pharmaceuticals Inc reported in its Form 8-K that on July 30, 2013, Conatus Pharmaceuticals Inc. (Company) issued 91,948 shares of its common stock to certain of its stockholders in connection with the completion of the initial public offering of shares of its common stock (IPO). The Conversion Shares were issued as a result of the automatic conversion of $1.0 million in aggregate principal amount of convertible promissory notes issued by the Company in May 2013, including accrued interest thereon, at a price per share of $11.00, the price at which shares of the Company‚Äôs common stock were sold to the public in the IPO (IPO Price). 

Company Quote

-0.2 -3.27%
1 Oct 2014